BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 30929914)

  • 1. Suppression of oncogenic protein translation via targeting eukaryotic translation initiation factor 4E overcomes chemo-resistance in nasopharyngeal carcinoma.
    Xu M; Tao Z; Wang S; Jiang Y; Qu M
    Biochem Biophys Res Commun; 2019 May; 512(4):902-907. PubMed ID: 30929914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ribavirin augments doxorubicin's efficacy in human hepatocellular carcinoma through inhibiting doxorubicin-induced eIF4E activation.
    Tan J; Ye J; Song M; Zhou M; Hu Y
    J Biochem Mol Toxicol; 2018 Jan; 32(1):. PubMed ID: 29112301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of eukaryotic translation initiation factor 4E is effective against chemo-resistance in colon and cervical cancer.
    Xi C; Wang L; Yu J; Ye H; Cao L; Gong Z
    Biochem Biophys Res Commun; 2018 Sep; 503(4):2286-2292. PubMed ID: 29959920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of eukaryotic initiation factor 4E phosphorylation by cercosporamide selectively suppresses angiogenesis, growth and survival of human hepatocellular carcinoma.
    Liu Y; Sun L; Su X; Guo S
    Biomed Pharmacother; 2016 Dec; 84():237-243. PubMed ID: 27662474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of eIF4E cooperates with chemotherapy and immunotherapy in renal cell carcinoma.
    Cao J; Sun X; Zhang X; Chen D
    Clin Transl Oncol; 2018 Jun; 20(6):761-767. PubMed ID: 29086249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repurposing the FDA-Approved Antiviral Drug Ribavirin as Targeted Therapy for Nasopharyngeal Carcinoma.
    Huq S; Casaos J; Serra R; Peters M; Xia Y; Ding AS; Ehresman J; Kedda JN; Morales M; Gorelick NL; Zhao T; Ishida W; Perdomo-Pantoja A; Cecia A; Ji C; Suk I; Sidransky D; Brait M; Brem H; Skuli N; Tyler B
    Mol Cancer Ther; 2020 Sep; 19(9):1797-1808. PubMed ID: 32606016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LMP1 stimulates the transcription of eIF4E to promote the proliferation, migration and invasion of human nasopharyngeal carcinoma.
    Zhao Y; Pang TY; Wang Y; Wang S; Kang HX; Ding WB; Yong WW; Bie YH; Cheng XG; Zeng C; Yao YH; Li Q; Hu XR
    FEBS J; 2014 Jul; 281(13):3004-18. PubMed ID: 24814906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of Eukaryotic Initiating Factor eIF4E Overcomes Abemaciclib Resistance in Gastric Cancer.
    Zha HL; Chen W; Shi W; Liao YY
    Curr Med Sci; 2023 Oct; 43(5):927-934. PubMed ID: 37752406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting of MNK/eIF4E overcomes chemoresistance in cervical cancer.
    Zhu Y; Wang C; Li M; Yang X
    J Pharm Pharmacol; 2021 Sep; 73(10):1418-1426. PubMed ID: 34254647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of eIF4E signaling by ribavirin selectively targets lung cancer and angiogenesis.
    Tan H; He L; Cheng Z
    Biochem Biophys Res Commun; 2020 Aug; 529(3):519-525. PubMed ID: 32736668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ribavirin Inhibits the Activity of mTOR/eIF4E, ERK/Mnk1/eIF4E Signaling Pathway and Synergizes with Tyrosine Kinase Inhibitor Imatinib to Impair Bcr-Abl Mediated Proliferation and Apoptosis in Ph+ Leukemia.
    Shi F; Len Y; Gong Y; Shi R; Yang X; Naren D; Yan T
    PLoS One; 2015; 10(8):e0136746. PubMed ID: 26317515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting EIF4E signaling with ribavirin in infant acute lymphoblastic leukemia.
    Urtishak KA; Wang LS; Culjkovic-Kraljacic B; Davenport JW; Porazzi P; Vincent TL; Teachey DT; Tasian SK; Moore JS; Seif AE; Jin S; Barrett JS; Robinson BW; Chen IL; Harvey RC; Carroll MP; Carroll AJ; Heerema NA; Devidas M; Dreyer ZE; Hilden JM; Hunger SP; Willman CL; Borden KLB; Felix CA
    Oncogene; 2019 Mar; 38(13):2241-2262. PubMed ID: 30478448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Knockdown of eIF4E suppresses cell proliferation, invasion and enhances cisplatin cytotoxicity in human ovarian cancer cells.
    Wan J; Shi F; Xu Z; Zhao M
    Int J Oncol; 2015 Dec; 47(6):2217-25. PubMed ID: 26498997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The androgen receptor is a negative regulator of eIF4E phosphorylation at S209: implications for the use of mTOR inhibitors in advanced prostate cancer.
    D'Abronzo LS; Bose S; Crapuchettes ME; Beggs RE; Vinall RL; Tepper CG; Siddiqui S; Mudryj M; Melgoza FU; Durbin-Johnson BP; deVere White RW; Ghosh PM
    Oncogene; 2017 Nov; 36(46):6359-6373. PubMed ID: 28745319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting the oncogene eIF4E in cancer: From the bench to clinical trials.
    Borden KL
    Clin Invest Med; 2011 Dec; 34(6):E315. PubMed ID: 22129918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. eIF4E promotes tumorigenesis and modulates chemosensitivity to cisplatin in esophageal squamous cell carcinoma.
    Liu T; Li R; Zhao H; Deng J; Long Y; Shuai MT; Li Q; Gu H; Chen YQ; Leng AM
    Oncotarget; 2016 Oct; 7(41):66851-66864. PubMed ID: 27588477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting eIF4E inhibits growth, survival and angiogenesis in retinoblastoma and enhances efficacy of chemotherapy.
    Wang G; Li Z; Li Z; Huang Y; Mao X; Xu C; Cui S
    Biomed Pharmacother; 2017 Dec; 96():750-756. PubMed ID: 29049978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphorylated Mnk1 and eIF4E are associated with lymph node metastasis and poor prognosis of nasopharyngeal carcinoma.
    Zheng J; Li J; Xu L; Xie G; Wen Q; Luo J; Li D; Huang D; Fan S
    PLoS One; 2014; 9(2):e89220. PubMed ID: 24551240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Over-expressions of p-eIF4E and p-4EBP1 are associated with poor prognosis in nasopharyngeal carcinoma].
    Zheng J; Zhang C; Zhang Y; Pei J; Fan S
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2017 Apr; 33(4):531-535. PubMed ID: 28395726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ribavirin suppresses eIF4E-mediated oncogenic transformation by physical mimicry of the 7-methyl guanosine mRNA cap.
    Kentsis A; Topisirovic I; Culjkovic B; Shao L; Borden KL
    Proc Natl Acad Sci U S A; 2004 Dec; 101(52):18105-10. PubMed ID: 15601771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.